Open AccessBreast Cancer in Pregnancy: Avoiding Fetal Harm When Maternal Treatment Is Necessary
Author(s) -
Cordeiro Christi.,
Gemignani Mary L.
Publication year - 2017
Publication title -
the breast journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.533
H-Index - 72
eISSN - 1524-4741
pISSN - 1075-122X
DOI - 10.1111/tbj.12780
Subject(s) - medicine , pregnancy , breast cancer , obstetrics , cancer , harm , adjuvant , fetus , chemotherapy , gestation , adjuvant chemotherapy , oncology , gynecology , genetics , political science , law , biology
The management of breast cancer during pregnancy poses unique challenges and requires a multi‐disciplinary approach. In this review, we discuss the treatment of breast cancer in pregnancy and recent updates regarding the safety of surgical and chemotherapeutic treatments, including both oncologic and fetal outcomes. The treatment of breast cancer during pregnancy mirrors that outside of pregnancy, with a few important differences dictated by the balance of maternal versus fetal health. Overall, surgical treatment, neo‐adjuvant chemotherapy, and/or adjuvant chemotherapy are feasible in most women during pregnancy. Further research to determine the safety of these therapies in pregnancy‐associated breast cancer is warranted.